Biotechnology firm Codagenix and Serum Institute of India (SII) have dosed the first patient in Phase I clinical trial of a single-dose, intranasal Covid-19 vaccine, COVI-VAC. Developed with Codagenix’s Synthetic

Public health experts believe that intranasal vaccines for coronavirus, administered through nose rather than muscles, can be a potential gamechanger in Indias fight against the coronavirus pandemic. The nasal vaccine

Trials have begun in London for the next generation of COVID-19 vaccines with the first dose for a new nasal vaccine being developed by the U.S. company Codagenix having been administered at

Dublin-listed Open Orphan has reported that its first volunteer has been dosed in an intranasal Covid-19 vaccine clinical trial. The volunteer was treated with the Codagenix needle free, intranasal Covid-19

The world’s first COVID-19 human challenge is about to start. Britain will infect 2,500 healthy volunteers with coronavirus to study how the infection behaves in the body — specifically the

In a move to help researchers in the study of the coronavirus, over 2,500 volunteers in the United Kingdom (UK) will participate in the ‘Human Challenge COVID-19 trials’ with each

A small Irish-based laboratory that conducts live trials testing potential Covid-19 and other vaccines for the British government is the biggest winner on the Irish stock exchange this year, with

Dublin-listed pharmaceutical services company Open Orphan has announced a contract renewal extending its consultancy services with a major global pharmaceutical client until December 2021. Open Orphan, a European-focused, rare and orphan drug